Objectives: This study investigated how different concentrations of doxorubicin (DOX) can affect the function of cardiac cells. This study also examined whether activation of prokineticin receptor (PKR)-1 by a nonpeptide agonist. IS20. prevents DOX-induced cardiovascular toxicity in mouse models. https://icemanvideoesgames.shop/product-category/figures/